Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.
Oncology R&D, AstraZeneca, Cambridge, CB21 6GP, United Kingdom.
Int J Oncol. 2020 Jul;57(1):87-99. doi: 10.3892/ijo.2020.5037. Epub 2020 Apr 3.
The immune checkpoint protein B7‑H4 plays an important role in the positive as well as the negative regulation of immune T‑cell responses. When expressed on cancer cells, B7‑H4 inhibits T‑cell activity, and numerous types of cancer cells use upregulation of B7‑H4 as a survival strategy. Thus, B7‑H4 is a potential target for anticancer drug therapy. Unfortunately, the cell biology of this molecule has yet to be fully elucidated. Even basic properties, such as the nature of B7‑H4 interactors, are controversial. In particular, the cis‑interactors of B7‑H4 on cancer cell plasma membranes have not been investigated to date. The present study used a proteomic proximity‑labelling assay to investigate the molecular neighbours of B7‑H4 on the surface of the human breast cancer cells SK‑BR‑3. By comparison to a comprehensive proteome analysis of SK‑BR‑3 cells, the proximity method detected a relatively small number of low abundance plasma membrane proteins highly enriched for proteins known to modulate cell adhesion and immune recognition. It may be inferred that these molecules contribute to the immunosuppressive behaviour that is characteristic of B7‑H4 on cancer cells.
免疫检查点蛋白 B7-H4 在免疫 T 细胞反应的正调控和负调控中发挥重要作用。当表达在癌细胞上时,B7-H4 抑制 T 细胞活性,许多类型的癌细胞利用 B7-H4 的上调作为一种生存策略。因此,B7-H4 是抗癌药物治疗的潜在靶点。不幸的是,该分子的细胞生物学尚未完全阐明。即使是基本特性,如 B7-H4 相互作用子的性质,也存在争议。迄今为止,尚未研究 B7-H4 在癌细胞质膜上的顺式相互作用子。本研究使用蛋白质组学邻近标记测定法来研究人乳腺癌细胞 SK-BR-3 表面 B7-H4 的分子邻居。与 SK-BR-3 细胞的综合蛋白质组分析相比,该接近方法检测到相对较少的低丰度质膜蛋白,这些蛋白富含已知调节细胞黏附和免疫识别的蛋白。可以推断,这些分子有助于 B7-H4 在癌细胞上的免疫抑制行为。